Home » Topics » Regulatory » Patents

Patents
RSS

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Cathepsin L inhibitors described by Takeda

July 19, 1996

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

July 19, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...